INTRODUCTION
Individuals with the Lesch-Nyhan syndrome exhibit a functional deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT)' which is necessary for the phosphoribosylpyrophosphate (PP-ribose-P)-dependent formation of inosine-5'-monophosphate (IMP) and guanosine-5'-monophosphate (GMP) from the purine bases hypoxanthine and guanine, respectively (1) . Clinically, the defect is manifested by hyperuricemia and hyperuricaciduria, self-mutilation, choreoathetosis, spasticity, and mental retardation (2) .
In addition to a deficiency of hypoxanthine-guanine phosphoribosyltransferase, several other biochemical abReceived for publication 21 October 1971 and in revised form 5 January 1972.
1 Abbreviations used in this paper: GMP, guanosine-5'-monophosphate; HGPRT, hypoxanthine-guanine phosphoribosyltransferase; IMP, inosine-5'-monophosphate; NAD+, nicotine adenine dinucleotide; PP-ribose-P, phosphoribosylpyrophosphate; XMP, xanthosine-5'-monophosphate. normalities have been consistently described in patients with the Lesch-Nyhan syndrome. These include an accelerated rate of purine biosynthesis (2) , increased intracellular levels of PP-ribose-P in both erythrocytes (3) and cultured skin fibroblasts (4) , and increased activity of the enzyme adenine phosphoribosyltransferase in erythrocytes (1, 5) . All of these effects may be interpreted as secondary manifestations of the deficiency of hypoxanthine-guanine phosphoribosyltransferase (5) .
In this paper we describe a significant and consistent elevation of activity of the enzyme inosinic acid (lehydrogenase in erythrocyte lysates from patients with the Lesch-Nyhan syndrome. Inosinic acid dehydrogenase (IMP: NAD' oxidoreductase, E.C. 1.2.1.14) catalyzes the nicotine adenine dinucleotide (NAD+) -dependent conversion of IMP to xanthosine-5'-monophosphate (XMP) and represents the first reaction unique to the synthesis de novo of GMP from IMP. This enzyme, which had not previously been assayed in human tissues, should play a critical role in the Lesch-Nyhan syndrome. In the absence of hypoxanthine-guanine phosphoribosyltransferase activity, the pathway initiated by IMP dehydrogenase represents the only known mechanism for the production of guanine nucleotides. Several different factors appear to be responsible for the observed increase in enzyme activity.
METHODS
Hypoxanthine-8-'4C (4.2, 52.0, and 60.1 mCi/mmole) was obtained from New England Nuclear Corp., Boston, Mass., Schwarz Bio Research Inc., Orangeburg, N. Y., and Amersham/Searle Corp., Arlington Heights, Ill., respectively.
Nicotine adenine dinucleotide (NAD1) was purchased from Sigma Chemical Company, St. Louis, Mo. The dimagnesium salt of PP-ribose-P and the tetra sodium salt of PP-ribose-P were obtained from P-L Biochemicals, Inc., Milwaukee, Wis., and Sigma, respectively. All other reagents were of the highest purity commercially available.
Five patients (E. S., J. K., W. E., D. C., and D. G.) with the Lesch-Nyhan syndrome were admitted to the Clinical Research Center at Duke Hospital where they were maintained on a diet essentially free of purines containing 1800 k-cal and 70 g protein. The only medications were allopurinol and diazepam which were found to have no effect on inosinic acid dehydrogenase levels. Hemolysates were also obtained from 10 other patients with the Lesch-Nyhan syndrome. These samples were stored at -20'C for varying periods of time before assay.
Blood obtained by venipuncture was twice washed with normal saline and centrifuged at 1200 g for 10 min. The washed, packed erythrocytes were frozen at -200C, thawed, and the resulting hemolysate dialysed against 0.05 M sodium phosphate buffer, pH 7.4, for 2 hr at 40C. All hemolysates obtained from normal volunteers were prepared in a similar manner and assayed within 2 wk unless otherwise specified.
Muscle tissue from patients with the Lesch-Nyhan syndrome was obtained by biopsy while muscle tissue from subjects with normal HGPRT activity was obtained either by biopsy or at autopsy. Enzyme activity was comparable in muscle obtained by either technique. Muscle tissue was homogenized in 10 vol of 0.05 M sodium phosphate buffer, pH 7.4. The homogenate was centrifuged at 13,000 g for 30 min and the supernate dialyzed in 0.05 M sodium phosphate buffer for 4 hr at 4°C.
Leukocytes were prepared by a modification of the method of Chodirker, Bock, and Vaughn (6) . Venous blood (25 ml) was drawn and immediately mixed with 475 ml of 0.85% NaCl with 0.1% bovine serum albumin. After centrifugation at 800 g for 30 min, the supernate was discarded and the pellet mixed with 100 ml of 0.2% NaCl for 20 sec and then restored to isotonicity by the addition of 100 ml of 1.61%o NaCl. The cells were centrifuged at 400 g for 10 min and the lysis procedure was repeated once. The cells obtained from this procedure were washed twice in cold isotonic saline. After the final wash the white cell pellet was dissolved in 0.01 M Tris buffer pH 7.4 (80 mg wet weight per ml). The cells were lysed by freezing and thawing twice in a dry ice and acetone bath. All leukocyte preparations were assayed for inosinic acid dehydrogenase within 24 hr of venipuncture.
Erythrocytes were fractionated according to their density after the method of Danon and Marikovsky (7) . These workers have demonstrated a linear relation between red cell density and age in vivo. Additionally, their findings with 'Fe-labeling in vivo suggest very little cross-contamination of old with young cells using this procedure. Methyl phthalate and di-n-butyl phthalate were mixed in different proportions to yield fluids with specific gravities of 1.090, 1.086, and 1.094. Freshly drawn, heparinized blood was placed in a Nalgene centrifuge tube (Nalge Co., Rochester, N. Y.) and 2 ml of the phthalate mixture of specific gravity 1.090 was layered on top of the whole blood. This was then centrifuged at 12,000 g for 90 min at 15°C effecting the primary separation. After removal of the plasma and buffy coat, the top and bottom layers were transferred to two separate centrifuge tubes. To the tube containing the top layer, 1 ml of the phthalate mixture of specific gravity 1.086 was added; 1 ml of phthalate of specific gravity 1.094 was added to the tube containing the bottom layer. These were again centrifuged at 12,000 g for 90 min at 15°C. The four layers which resulted from this procedure were washed three times with normal saline and the cells lysed by freezing and thawing twice. The hemolysates were then dialyzed in 0.05 M sodium phosphate, pH 7.4, for 2 hr and assayed.
Inosinic acid dehydrogenase activity was determined by quantitating the production of xanthosine monophosphate (XMP)-'4C utilizing modifications of the assays developed by Salser and Balis (8) (10) .
IMP-8-14C of sufficient purity and specific radioactivity for this study was not commercially available. Therefore, IMP-8-14C was enzymatically synthesized from hypoxanthine-8-14C using a partially purified preparation of HGPRT prepared as described below. The reaction mixture contained 1.0 Amoles of hypoxanthine-8-'4C, 2.0 Amoles of PP-ribose-P, 5 Amoles of Mg", 10 gmoles of Cl-, 0.08 Amoles of Tris HCl, pH 7.4, and 1.6 mg of partially purified human HGPRT with a specific activity of 9000 nmoles/mg per hr in a final volume of 0.650 ml. The reaction mixture was incubated for 90 min at 37'C, and the reaction was stopped by the addition of 500 Al of 95%o ethanol and 25 /Ll of 0.1 M Na2 EDTA. Protein was removed by heating for 90 sec in a boiling water bath and centrifugation for 30 min at 10,000 rpm. The IMP thus formed was stored at -20'C and used within 2 wk. The radioactive product formed was 97%o IMP and 3% inosine. Identity of the major product as inosinic acid was confirmed by co-chromatography with authentic IMP in two ascending chromatography systems (1.0 M ammonium acetate, pH 5 verted to GMP, the formation of GMP-"C was determined. Under standard assay conditions, no GMP-14C was formed in hemolysates from either normal or Lesch-Nyhan subjects.
Michaelis constants for both substrates of inosinic acid dehydrogenase were determined for the enzyme derived from patients with the Lesch-Nyhan syndrome and for the enzyme derived from normal hemolysate. A partially purified preparation of the enzyme present in erythrocytes was used in both cases with the nonvariable substrate at saturating concentrations. The Michaelis constant was estimated from double reciprocal plots. For the normal enzyme the Km (IMP) was 5.0 X 10' M and the Km (NAD+) was 2.0 X 10-' M. For the Lesch-Nyhan enzyme the Km (IMP) was 7.7 X 10' M while the Km (NAD+) was 3.4 X 10-' M. No significance was attached to these differences.
Fresh erythrocytes from normal subjects and from patients with the Lesch-Nyhan syndrome were fractionated into four groups of increasing density (age) as described in methods. The relationship between erythrocyte age in vivo and inosinic acid dehydrogenase activity is presented in Fig. 1 . Inosinic acid dehydrogenase activity was higher in each cell fraction in patients with the Lesch-Nyhan syndrome as compared to normal. Multivariate analysis of variance was performed to assess the significance of the observed difference between normal and Lesch-Nyhan patients at each point and of the curves as a whole. Differences yielded significant P values for all points except for the lowest density fraction (youngest cells) where no significant difference between the means was observed.
The overall difference between the curves was significant at the 0.0001 level. These results suggest that inosinic acid dehydrogenase is stabilized in vivo in erythrocytes from patients with the Lesch-Nyhan syndrome. Alternatively, these findings could be explained by accumulation of an "inhibitor" in the normal erythrocytes with age.
Further evidence for stabilization of inosinic acid dehydrogenase in erythrocytes from subjects with the Lesch-Nyhan syndrome was obtained from a study of the heat stability of the enzyme in vitro. Enzyme activity present after heating at 60°C for 4 min was compared with the unheated control. In hemolysates derived from four patients with the Lesch-Nyhan syndrome, 64.5+6.1% (SD) of the original activity remained after heating. Only 38.8±9.6% (SD) of the control activity was present after heating hemolysates from four normal subjects.
To further assess possible mechanisms responsible for this stabilization in vivo, protection of inosinic acid dehydrogenase against thermal denaturation was studied using a preparation of the enzyme partially purified from a normal subject. The effect of substrates for the enzyme as well as PP-ribose-P in concentrations found in normal individuals (5 X 10' M) and in patients with the Lesch-Nyhan syndrome (5 X 10' M) (3) was investigated. PP-ribose-P at concentrations exceeding those found in vivo did not stabilize the enzyme. IMP and NAD' provided moderate protection of the enzyme against heat inactivation at the concentrations used in the enzyme assay (Fig. 2) types were below the level of detectability in our assay. Accordingly, the exact factors responsible for the stabilization in vivo and in vitro remain unclear.
Another mechanism for the difference in inosinic acid dehydrogenase, activity in erythrocytes between normal and Lesch-Nyhan subjects was suggested when it was noted that during purification of the normal enzyme, substantially more total activity was recovered in the purified form than had been assayable in the hemolysate dialyzed for 2 hr. This phenomenon appeared much less striking when the enzyme from LeschNyhan hemolysate was treated in a similar fashion. For example, enzyme activity from normal erythrocytes was accentuated by DEAE-cellulose chromatography whereas the enzyme from Lesch-Nyhan hemolysate exhibited no activation (Table III) . Similar results were observed with hemolysate from other normal and Lesch-Nyhan subjects.
Prolonged dialysis against 0.05 M sodium phosphate buffer pH 7.4 was found to be another method of "activating" the enzyme present in normal hemolysate. Fig. 3 7 .4, which contained either 2 X 10' M reduced glutathione (GSH), 1 X 10-3 M dithiothreitol (DTT), or no sulfhydryl reducing agent. The activity of inosinic acid dehydrogenase in the hemolysates from normal and Lesch-Nyhan patients was not altered by the sulfhydryl reducing agents. This suggests that the difference in inosinic acid dehydrogenase activity cannot be attributed to a difference in the state of oxidation of the sulfhydryl groups of the enzyme in these two groups of subjects.
DISCUSSION
Inosinic acid dehydrogenase catalyzes the NAD+-dependent conversion of IMP to XMP and represents the first reaction unique to the synthesis of GMP de novo from IMP (14) . The enzyme derived from nonhuman sources has been shown to be subject to feedback inhibition by GMP (15) and can be repressed in bacterial systems (16 
